Photo credit: www.sciencedaily.com

New Insights into Zika Virus Transmission and Mechanisms

The Zika virus outbreak that began in 2015 raised significant alarm in the Americas due to its association with severe birth defects in newborns. Transmitted primarily through mosquito bites, Zika generally causes mild symptoms in adults. However, when a pregnant woman is infected, the virus can lead to grave developmental issues in the fetus. A key question arises: how does Zika successfully cross the placental barrier?

Researchers from Penn State and Baylor College of Medicine have made an important discovery regarding this transmission process. Their study reveals that the Zika virus utilizes specialized structures called tunneling nanotubes to facilitate the transport of viral components, including in placental cells. This mechanism potentially allows the virus to transfer from the mother to the fetus undetected by the immune system. Notably, the study identifies the non-structural protein 1 (NS1) of the virus as a critical player in the formation of these nanotubes.

These findings, shared in the journal Nature Communications, represent a significant advancement in understanding the Zika virus’s transmission dynamics and may indicate new avenues for prevention strategies and antiviral treatments. The research was made possible by a nearly $4 million grant from the U.S. National Institute of Allergy and Infectious Diseases, awarded in 2024.

“To infect newborns, Zika must effectively navigate the placental barrier, which typically filters what substances can cross,” noted Anoop Narayanan, a research professor and senior author of the study. “This discovery could lead us to methods of preventing the virus from reaching the fetus, which is vital in controlling its spread.”

Zika belongs to the Orthoflavivirus genus within the Flaviviridae family, which also includes notable viruses such as West Nile and dengue. Notably distinct, Zika can be transmitted directly between humans without the involvement of insect vectors and is unique in its ability to cross the placenta.

While Zika infections in adults are often mild, the implications for pregnant women can be severe, with potential neurological disorders and other birth defects in their infants. Currently, there are no vaccines or antiviral treatments specifically targeting the Zika virus.

“Preventing the transmission of Zika to the fetus is crucial,” stated Joyce Jose, an associate professor and co-author of the study. As human infections have declined, Jose highlighted that the risk of future outbreaks persists, especially as changing climates may enable the spread of Zika-bearing mosquitoes into new areas.

The researchers serendipitously discovered Zika’s ability to form tunneling nanotubes while observing infected cells under a fluorescent microscope at Penn State. They noticed these structures connecting adjacent cells, which were absent in infections caused by other viruses such as dengue or yellow fever. Their collaboration with Baylor researchers corroborated these observations, particularly within placental cells, leading to a deeper investigation into this viral characteristic.

Other viruses, including HIV, herpes, and SARS-CoV-2, are known to create similar tunnels for cell-to-cell transmission. However, these viruses do not have the ability to cross the placenta. Through in vitro experiments using human placental cells, the team confirmed that infected cells utilize nanotubes to extend their reach, spreading viral particles to neighboring uninfected cells.

The nanotubes not only allow the transfer of viral material but also facilitate a two-way flow of resources. Mitochondria, which are essential for cellular energy, can migrate from uninfected to infected cells through these structures, effectively supporting the virus’s survival and replication.

“The virus essentially reprograms the host cell to ensure its own growth and propagation by utilizing resources like mitochondria,” explained Narayanan.

Furthermore, the discovery of NS1 as the protein responsible for nanotube formation is significant because it highlights a unique aspect of Zika compared to other flaviviruses. The specific segment of the NS1 protein implicated in this process was identified by Shay Toner, a doctoral student who contributed key findings as part of his undergraduate research at Penn State.

“My interest in virology stemmed from the Zika outbreak in 2015, and being able to work on this groundbreaking project as an undergraduate was an incredible experience,” Toner remarked.

Looking ahead, the research team aims to further investigate the signaling pathways activated by NS1 that lead to nanotube formation. This understanding could open doors to developing antiviral medications. The team is also planning to conduct studies utilizing mouse models to expand on their findings.

“This is a complex puzzle,” Jose concluded, emphasizing the ongoing nature of their research to decipher the mechanisms behind these intriguing viral structures.

Additional co-authors from Baylor include Indira Mysorekar and Rafael Michita, among others. The investigation received support from various NIH grants, further underscoring the collaborative efforts in tackling this public health concern.

Source
www.sciencedaily.com